hPEBP4 as a predictive marker for the pathological response of rectal cancer to preoperative radiotherapy

[1] Janjan NA(1999)Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M.D. Anderson cancer center experience Int J Radiat Oncol Biol Phys 44 1027-1038

[2] Khoo VS(2002)T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival Dis Colon Rectum 45 895-903

[3] Abbruzzese J(1998)Prognostic implications of downstaging following preoperative radiation therapy for operable T3–T4 rectal cancer Int J Radiat Oncol Biol Phys 42 935-941

[4] Theodoropoulos G(2000)Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study Int J Radiat Oncol Biol Phys 48 843-856

[5] Wise WE(2005)Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial J Clin Oncol 23 8697-8705

[6] Padmanabhan A(2009)Postoperative morbidity following chemoradiation for locally advanced low rectal cancer J Gastrointest Surg 13 657-667

[7] Kaminsky-Forrett MC(2006)p53 and p27 as predictors of clinical outcome for rectal-cancer patients receiving neoadjuvant therapy Surg Oncol 15 211-216

[8] Conroy T(2009)Biomarkers for response to neoadjuvant chemoradiation for rectal cancer Int J Radiat Oncol Biol Phys 74 673-688

[9] Luporsi E(2007)The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of Polo-like kinase 1 Curr Biol 17 304-315

[10] Chan AK(2007)BI 2536, a potent and selective inhibitor of Polo-like kinase 1, inhibits tumor growth in vivo Curr Biol 17 316-322

[1] Janjan NA(1999)Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M.D. Anderson cancer center experience Int J Radiat Oncol Biol Phys 44 1027-1038

[2] Khoo VS(2002)T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival Dis Colon Rectum 45 895-903

[3] Abbruzzese J(1998)Prognostic implications of downstaging following preoperative radiation therapy for operable T3–T4 rectal cancer Int J Radiat Oncol Biol Phys 42 935-941

[4] Theodoropoulos G(2000)Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study Int J Radiat Oncol Biol Phys 48 843-856

[5] Wise WE(2005)Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial J Clin Oncol 23 8697-8705

[6] Padmanabhan A(2009)Postoperative morbidity following chemoradiation for locally advanced low rectal cancer J Gastrointest Surg 13 657-667

[7] Kaminsky-Forrett MC(2006)p53 and p27 as predictors of clinical outcome for rectal-cancer patients receiving neoadjuvant therapy Surg Oncol 15 211-216

[8] Conroy T(2009)Biomarkers for response to neoadjuvant chemoradiation for rectal cancer Int J Radiat Oncol Biol Phys 74 673-688

[9] Luporsi E(2007)The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of Polo-like kinase 1 Curr Biol 17 304-315

[10] Chan AK(2007)BI 2536, a potent and selective inhibitor of Polo-like kinase 1, inhibits tumor growth in vivo Curr Biol 17 316-322